Razoxane


CAS No. : 21416-67-1

(Synonyms: ICRF 159)

21416-67-1
Price and Availability of CAS No. : 21416-67-1
Size Price Stock
100mg $86 In-stock
250mg $129 In-stock
1g $323 In-stock
5 g Get quote
10 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-119425
M.Wt: 268.27
Formula: C11H16N4O4
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 21416-67-1 :

Razoxane (ICRF 159), a EDTA (HY-Y0682) derivative, is an orally active antiangiogenic topoisomerase II inhibitor. Razoxane has antineoplastic, antiangiogenic, and antimetastatic activities. Razoxanecan be used for the research of renal cell carcinoma (RCC), lung cancer and melanoma cancer[1][2]. In Vivo:Razoxane (30 mg/kg; i.p.) exhibits antimetastatic effects in a rat osteosarcoma model[2].
Early treatment with Razoxane (30 mg/kg i.p. from day -2 to +14) shows a greater inhibition of pulmonary metastases than later treatment (30 mg/kg i.p. from day +14 to +28 after transplantation)[2].

Your information is safe with us.